Fundraising achievements

CHANGE IS HAPPENING – support Equilibrium and BE PART OF IT

We’re always keen to hear about your ideas for fundraising events and opportunities of raising the profile about bipolar and Equilibrium. Many people support us in a variety of fun and interesting ways through sponsored sports events, creative performances and shows, and through setting up memory pages. Please contact us to share your ideas and views on how we can optimize our fundraising activities and to tell us about an event you are planning.

You can download our fundraising brochure here, or contact us if you would like to be sent printed copies.

“I am very excited to learn about this organization and to be able to assist in the continuing journey of learning more about bipolar disorder.”
- Quote from a web user.

“Thank you for doing this! Living with this disorder is Hell! I’ve heard people say that they would miss it if it went away completely, but I’m not in that category. I wish it would go away for ever and I’d have no regrets!!!”
- Quote from a web user.

Your generosity has recently achieved:

Two new research fellowships

  • Developing New Psychotherapies – University of Oxford
  • Psychiatric Genetics – University College London.

International Bipolar Survey

  • First stage completed – 3,500 world-wide volunteers
  • Data supports the rationale for our mission and will be used in further research and supporting projects.

International Professional Advisory Council

  • A growing number of professional clinicians who are leaders in their field are joining Equilibrium as council members. They represent international current research in mood disorder related conditions.

Genetic studies of bipolar disorders

  • 400 volunteers contributed in leading studies through Equilibrium.

Links in four continents

  • Links to advocacy organisations are growing through the website across four continents.

Development of a new ‘tool’

  • For use in research and clinical practice to identify treatment related side-effects in people receiving medication for bipolar disorders.